Pubblicazioni

THE IELSG-32 TRIAL: RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE AND HIGH-DOSE CYTARABINE WITH OR WITHOUT THIOTEPA, AND WITH OR WITHOUT RITUXIMAB, FOLLOWED BY BRAIN IRRADIATION VS HIGH-DOSE CHEMOTHERAPY SUPPORTED BY AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR IMMUNOCOMPETENT PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA

2015 - HAEMATOLOGICA45th Congress of the Italian-Society-of-Hematology

Ferreri, Ajm; Cwynarski, K; Pulczynski, E; Ponzoni, M; Politi, Ls; Ambrosetti, A; Vitolo, U; Ilariucci, F; Balzarotti, M; Fabbri, A; Tucci, A; Pisani, F; Levis, A; Cabras, Mg; D'Arco, M; Zaccaria, A; Angrilli, F; Guarini, Anna; Imola, M; Martelli, Maurizio; Cervetti, J; Zaja, F; Pinto, A; Liberati, M; Morra, E; Cortellazzo, Sf; Bassan, R; Foppoli, M; Citterio, G; Sassone, M; Scarfo, L; Cavalli, F; Finke, J; Reni, M; Zucca, E; Illerhaus, G.